Anti-Obesity Drug Discovery and Development Volume 3. (Record no. 127174)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05390nam a22004693i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC4877812 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729131304.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2017 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781681081878 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781681081885 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC4877812 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL4877812 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr11398513 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)990408952 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC628.A585 2017 |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.39800000000002 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Rahman, Atta-ur. |
| 245 10 - TITLE STATEMENT | |
| Title | Anti-Obesity Drug Discovery and Development Volume 3. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Sharjah : |
| Name of producer, publisher, distributor, manufacturer | Bentham Science Publishers, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2017. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2017. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (245 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Anti-Obesity Drug Discovery and Development ; |
| Volume/sequential designation | v.3 |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- CONTENTS -- PREFACE -- List of Contributors -- Current Status of Medical Therapy and New Targets for Anti-Obesity Drug Development -- Chihiro Okuma, Yukihito Ishii and Takeshi Ohta* -- INTRODUCTION -- Approved Drugs -- Phentermine -- Mazindol -- Fenfluramine/Dexfenfluramine -- Orlistat -- Shibutramine -- Rimonabant -- Qsymia -- BELVIQ (Lorcaserin) -- Contrave -- New Drug Targets (Table 3) -- Late Phase Clinical Development -- Early Phase Clinical Stage Development or Pre-Clinical Development Stage Late Phase Clinical Development -- Future Prospects -- Obesity Animal Models -- ob/ob Mouse -- db/db Mouse -- KK-Ay Mouse -- TSOD Mouse -- SDT fatty Rat -- ZF Rat -- ZDF Rat -- cp/cp Rat -- WBN/Kob fatty Rat -- DIO Models -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Unravelling Potential Anorexigen Effects of Nesfatin-1: How Homeostatic Mechanisms Help Balance Excess Calories -- Carmine Finelli* -- INTRODUCTION -- Nesfatin-1/NUCB-2 and Anorexigenic Effect -- The Oxytocin Pathway in Nesfatin-1's Inhibitory Effect on Food Intake -- Nesfatin-1 and CRF -- Nesfatin-1 and Anti-Obesity Treatment -- Nesfatin-1 and Food Behaviour Control -- Nesfatin-1 and Signaling Pathway -- Nesfatin-1 and Eating Disorders -- CONCLUSIVE REMARKS -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- ABBREVIATIONS -- REFERENCES -- Proteomics in the Characterization of New Target Therapies in Pediatric Obesity Treatment -- Gillian E. Walker1,*, Marilisa De Feudis1, Marta Roccio1, Gianni Bona2 and Flavia Prodam2 -- INTRODUCTION -- CHILDHOOD OBESITY: PATHOLOGICAL BASIS -- Genetic Considerations for Childhood Obesity -- Energy Homeostasis Dysregulation -- Pathophysiology of Adipose Tissue -- PROTEOMICS -- Gel Based Methods -- Non Gel Based Methods: Mass Spectrometry (MS) -- Chips -- Challenges -- PROTEOMIC STUDIES OF ADIPOSE TISSUE -- WAT Depots -- WAT Secretome. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | BAT -- Stromal-Vascular Fraction (SVF) -- PROTEOMIC STUDIES IN ADIPOCYTES: STEM CELLS AND CELL LINES -- Adipogenesis: Adipo-proteomics -- Murine 3T3-L1 Preadipocytes -- Adipocyte-Derived Stem Cells (ASCs) -- Adipocyte Secretome -- Post-Translational Modifications (PTMs) -- PROTEOMIC PROFILING: TISSUES AND CIRCULATION -- Fetal Programming: Tissue-Specific Biomarkers -- Circulating Biomarkers -- Urine Biomarkers -- OUTLOOKS -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- ABBREVIATIONS -- REFERENCES -- Relationship Between Hormonal Milieu and Oxidative Stress in Childhood Obesity: A Physiopathological Basis for Antioxidant Treatment and Prevention of Cardiovascular Risk -- Antonio Mancini*, Francesco Leo, Chantal Di Segni, Sebastiano Raimondo and Aurora Natalia Rossodivita -- INTRODUCTION -- OBESITY AND OXIDATIVE STRESS -- Hormones and Inflammatory Molecules Produced by or Related to Adipose Tissue -- Oxidative Stress in Childhood Obesity -- HORMONAL REGULATION OF ANTIOXIDANT SYSTEMS AND THEIR DERANGEMENT IN CHILDHOOD OBESITY -- Growth Hormone (GH) -- Thyroid -- Adrenal Glands -- Gonads -- Adipose tissue (Leptin and Kisspeptin) -- ANTIOXIDANT-ENRICHED DIET AS A TREATMENT FOR OBESITY -- CONCLUSION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- The Role of Gut Microflora in Obesity - Does the Data Provide an Option for Intervention? -- Parth J. Parekh1, Edward C. Oldfield, IV2, Amrit Lamba3 and David A. Johnson4,* -- INTRODUCTION -- OBESITY AND THE MICROFLORA: A BRIEF OVERVIEW -- DATA AND OPTIONS FOR INTERVENTION -- Antibiotics -- Probiotics -- Prebiotics -- Synbiotics -- The Role of Fecal Transplant -- CONCLUSION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- SUBJECT INDEX. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Obesity. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Choudhary, M. Iqbal. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Rahman, Atta-ur |
| Title | Anti-Obesity Drug Discovery and Development Volume 3 |
| Place, publisher, and date of publication | Sharjah : Bentham Science Publishers,c2017 |
| International Standard Book Number | 9781681081885 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Anti-Obesity Drug Discovery and Development |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=4877812">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=4877812</a> |
| Public note | Click to View |
No items available.